Today, research on diabetes is being widely conducted, with a steady stream of findings emerging. Notably, diabetes, as a broad category, encompasses many specialized subfields. It has become clear that diabetes is not merely a single disease; more importantly, it is highly interdisciplinary. This is reflected not only in diabetes health management but also in […]
Category: Diabetes news
Phase II Clinical Trial Results of Ganli Pharmaceutical’s Innovative Once‑Weekly Insulin Injection GZR4 Published in the Top International Academic Journal Metabolism
Recently, findings from a Phase II clinical trial conducted in China for GZR4 injection, a Class 1 innovative once‑weekly basal insulin independently developed by Ganli Pharmaceutical, have been officially published in Metabolism‑Clinical and Experimental (commonly referred to as Metabolism), a prestigious international journal in endocrinology. As a globally recognized top academic journal in endocrinology and […]
Rapidly Increasing Incidence of Thyroid-Associated Ophthalmopathy and Thyroid Cancer
Given the scarcity of epidemiological data on pediatric Graves’ disease (GD), Polkampally et al. used insurance data to report that the incidence of GD among individuals aged 0–18 years in the United States from 2007 to 2022 was 3.33 per 100,000, with an annual increase of 0.042 per 100,000. The highest incidence was observed in […]
Latest Study: Half of Women Experience Recurrent Gestational Diabetes Mellitus (GDM), with Highly Predictable Risk
A recent study published in Diabetes Research and Clinical Practice shows that more than half of women with a history of gestational diabetes mellitus (GDM) experience recurrence in a subsequent pregnancy.Advanced maternal age and pre-pregnancy obesity are the strongest predictors of GDM recurrence. Other factors that significantly increase recurrence risk include a history of macrosomia, […]
Dr. Osagie Ebekozien, ADA Chief Quality Officer: Urgent Need for Scientific Translation
At the 85th Scientific Sessions of the American Diabetes Association (ADA 2025) held in Chicago, Dr. Osagie Ebekozien, Chief Quality Officer of the ADA, began by noting that diabetes holds profound personal meaning for him, inspiring his career-long commitment to supporting people living with diabetes and reinforcing his dedication to improving their health outcomes. He […]
Dr. Charles Henderson, CEO of ADA: Four Pillars Anchor the Future of Diabetes
At the 85th Scientific Sessions of the American Diabetes Association (ADA 2025) held in Chicago, Dr. Charles Henderson, Chief Executive Officer of the ADA, delivered the opening address, reviewing the Association’s 85-year history and announcing its four strategic pillars and core focus areas.In his opening remarks, Dr. Charles Henderson stated that for 85 years, the […]
Unraveling the Immune Regulatory Mechanisms in Type 1 Diabetes Remission
Type 1 diabetes (T1D) is an autoimmune disease pathologically characterized by T‑cell‑mediated destruction of pancreatic islet β‑cells.Clinically, some patients with new‑onset T1D experience a transient remission phase, known as the “honeymoon period”: residual β‑cell function is partially restored, glycemic control is improved, and exogenous insulin requirements are reduced.However, the mechanisms underlying the initiation and maintenance […]
Banting Science Achievement Award Recipient: Development of Amyloid Inhibitors Promising to Slow T2DM Progression
At the 85th Scientific Sessions of the American Diabetes Association (ADA 2025), the presentation of the Banting Medal for Scientific Achievement was undoubtedly one of the most anticipated highlights. As the highest scientific honor of the ADA, this award commemorates Dr. Frederick Banting—the medical scientist, physician, and Nobel laureate who played a pivotal role in […]
Many Scholars in Endocrinology and Metabolism Named in Elsevier 2025 List of Highly Cited Chinese Researchers
On January 30, 2026, Elsevier officially released the 2025 Highly Cited Chinese Researchers list. Based on Scopus, the globally recognized authoritative citation and indexing database, the list evaluates research outputs by Chinese scholars using a proprietary methodology developed by ShanghaiRanking Consultancy, ensuring its professionalism and objectivity.The 2025 list includes a total of 6,310 scholars from […]
Two Phase III Studies of Mazdutide Published in Nature
Recently, the results of two Phase III clinical studies (DREAMS-1 and DREAMS-2) of mazdutide in Chinese patients with type 2 diabetes mellitus (T2DM) have been jointly published in the prestigious journal Nature.Following presentations at the Scientific Sessions of the American Diabetes Association (ADA) and the Annual Meeting of the European Association for the Study of […]